Role of p53 mutations in the radiosensitivity status of tumor cells

Tumori. 1998 Sep-Oct;84(5):517-20. Role of p53 mutations in the radiosensitivity status of tumor cells. Chiarugi V, Magnelli L, Cinelli M. Source Laboratory of Molecular Biology, Institute of General Pathology, University of Florence, Italy. Abstract Wild-type p53 is involved in cellular response to DNA damage including cell cycle control, DNA repair and activation of apoptosis. Accumulation of p53 protein following DNA damage may initiate the apoptotic process, resulting in cell death. DNA damage induced by radiation is an example of apoptotic stimulus involving p53. Regulation of apoptosis by p53 can occur through transcriptional regulation of pro-apoptotic (e.g. bax) and anti-apoptotic (e.g. bel-2) factors. Although wild-type p53 usually sensitizes cells to radiation therapy, p53 mutations have a variable effect on radiation response. For example p53 mutations in bone or breast tumors have been found to be associated with resistance to chemotherapeutic drugs or ionizing radiation. Mutated p53 has has been reported to increase sensitivity to radiation and drugs in colorectal and bladder tumors. The present brief commentary tries to find an explanation at molecular level of these conflicting results. PMID: 9862508 [PubMed - indexed for MEDLINE]